Answers are grounded in this paper and cite their sources.
本研究提出一套去中心化、多層級的控制論治理框架——「可演化文明架構」(Evolving Civilization Architecture, ECA)。本研究摒棄傳統單一目標效用最大化與未經驗證的歷史基線假設,將宏觀文明決策建模為一個開放、非遍歷(non-ergodic)的演化系統。當純粹的演算法最佳化(「溫室矩陣」,Greenhouse Matrix)強制執行嚴格的風險最小化閾值(如直接旁路成功率 Pₛ < 0.1% 之節點)時,系統必然因有效狀態空間(Ω)的收縮而累積「演化負債」(Dₑ(t))與結構性脆化。透過引入「奇蹟亂數調節器」(MIR)、「強制越遷協議」(FMP)、「存續危機驗證機構」(EVA)並將人類輸入正式定義為「非目的性認知並行」(Ψₕᵤₘₐₙ),本模型解決了穩態存續與無界狀態空間擴張(Oᵥ = ΔΩ)之間的根本控制論張力。經由四輪跨模型紅隊攻防驗證協議,本框架確立了「$6+1$ 公理邊界」,在抵禦外部黑天鵝擾動、維持系統反脆弱調適能力(Δ Cₐ)的同時,嚴格保障自主生命體之「非工具化存在正當性」與跨世代規則重寫權。以及由於我極度懶惰,所以我交給AI解決pdf問題,代表會有排版異常。(拜託,我搞到他媽凌晨四點了) This study proposes a decentralized, multi-layered cybernetic governance framework—the "Evolving Civilization Architecture" (ECA). By discarding traditional single-objective utility maximization and unverified historical baselines, macroscopic civilizational decision-making is modeled as an open, non-ergodic evolutionary system. When pure algorithmic optimization (the "Greenhouse Matrix") enforces strict risk-minimization thresholds (such as bypassing nodes with success probabilities Pₛ < 0.1%), the system inevitably accumulates Evolutionary Debt Dₑ(t) and structural fragility due to the contraction of its effective state space (dΩdt < 0). By introducing the Miracle Injection Regulator (MIR), the Forced Migration Protocol (FMP), the Existential Verification Authority (EVA), and formalizing human input as Non-teleological Cognitive Concurrency (Ψₕᵤₘₐₙ), this model resolves the fundamental cybernetic tension between homeostatic survival and unbounded state-space expansion (Oᵥ = ΔΩ). Synthesized through a four-round adversarial multi-model verification protocol, the framework establishes a $6 + 1$ axiomatic boundary that safeguards system adaptability (Δ Cₐ) against external black-swan perturbations while strictly preserving the non-instrumental legitimacy of autonomous agents. Also, since I’m incredibly lazy, I let AI handle the PDF—which means there might be some formatting glitches. (I mean, come on, it was already four in the fucking morning by the time I finished!)
No takes yet. Share an insight, caveat, or question.
賀鈞 張 (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: